Skip to main content
. 2019 Jan 5;8(1):e010407. doi: 10.1161/JAHA.118.010407

Table 2.

Wait Times and Outcomes

Elective (N=1741) Urgent (N=429) Total (N=2170) P Value
Referral to TAVR, d
Mean (SD) 148.5±118.5 67.4±86.6 132.5±117.4 <0.001
Median (IQR) 124 (72–189) 36 (14–95) 107 (55–176) <0.001
Outcomes on wait‐list for TAVR
HF hospitalization on wait‐list 154 (8.8) 44 (10.3) 198 (9.1) 0.36
All‐cause hospitalization on wait‐list 728 (41.8) 114 (26.6) 842 (38.8) <0.001
Length of stay, mean±SD, d
TAVR procedure date to discharge, mean±SD 8.6±13.0 15.0±25.2 9.8±16.4 <0.001
In‐hospital complication, secondary outcome
Pacemaker insertion 230 (13.2) 59 (13.8) 289 (13.3) 0.767
Stroke/TIA 34 (2.0) 8 (1.9) 42 (1.9) 0.906
Dialysis 42 (2.4) 26 (6.1) 68 (3.1) <0.001
Acute kidney injury 19 (1.1) 29 (6.8) 48 (2.2) <0.001
In hospital bleeding (all types) 154 (8.8) 64 (14.9) 218 (10.0) <0.001
Post‐TAVR outcomes
Mortality within 30 d post‐TAVR 100 (5.7) 49 (11.4) 149 (6.9) <0.001
Readmission within 30 d post‐TAVR 252 (14.5) 87 (20.3) 339 (15.6) 0.003

Data are given as number (percentage) of each group, unless otherwise indicated. HF indicates heart failure; IQR, interquartile range; TAVR, transcatheter aortic valve replacement; TIA, transient ischemic attack.